Try our Advanced Search for more refined results
Connecticut Retirement v. Amgen Inc et al
Case Number:
2:07-cv-02536
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Barrack Rodos
- Berger Montague
- Berman Tabacco
- Glancy Prongay
- Hueston Hennigan
- Irell & Manella
- Kahn Swick
- Kohn Swift
- Labaton Keller
- Lieff Cabraser
- LimNexus
- Lockridge Grindal
- Mayer Brown
- Milberg Coleman
- Nelson & Fraenkel
- Robbins Geller
- Sheppard Mullin
- Stoll Keenon
- Stull Stull
- Susman Godfrey
- Zimmerman Reed
Companies
Sectors & Industries:
-
October 26, 2016
Labaton Secures $23.8M In Fees For Amgen Securities Deal
A California federal judge on Wednesday granted $23.8 million in attorneys' fees to Labaton Sucharow LLP and others serving as class counsel to investors who reached a $95 million settlement with Amgen Inc. over the company's alleged misstatements about two of its anti-anemia drugs.
-
July 20, 2016
Amgen To Pay $95M In Class Action Securities Settlement
Global biotechnology company Amgen Inc. has reached a $95 million settlement with investors over alleged misstatements about two of its anti-anemia drugs, according to settlement documents filed in California federal court Wednesday, bringing nearly a decade of class action litigation to a close.
-
November 08, 2011
9th Circ. Keeps Investor Class Intact In Anemia Drug Fight
The Ninth Circuit refused on Tuesday to decertify a class of shareholders in a case alleging Amgen Inc. misled investors about two top-selling anemia drugs, ruling the suit plausibly alleged the biotech company's statements were both false and material.